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Abstract 
Fluorescence properties of two new potential antitumoral tetracyclic thieno[3,2-b]pyridine derivatives 
were studied in solution and in liposomes of DPPC (dipalmitoyl phosphatidylcholine), egg lecithin 
(phosphatidylcholine from egg yolk; Egg-PC) and DODAB (dioctadecyldimethylammonium 
bromide). Compound 1, pyrido[2′,3′:3,2]thieno[4,5-d]pyrido[1,2-a]pyrimidin-6-one, exhibits 
reasonably high fluorescence quantum yields in all solvents studied (0.20 ≤ ΦF ≤ 0.30), while for 
compound 2, 3-[(p-methoxyphenyl)ethynyl]pyrido[2′,3′:3,2]thieno[4,5-d]pyrido[1,2-a]pyrimidin-6-
one, the values are much lower (0.01 ≤ ΦF ≤ 0.05). The interaction of these compounds with salmon 
sperm DNA was studied using spectroscopic methods, allowing the determination of intrinsic binding 
constants, Ki = (8.7 ± 0.9) × 103 M−1 for compound 1 and Ki = (5.9 ± 0.6) × 103 M−1 for 2, and binding 
site sizes of n = 11 ± 3 and n = 7 ± 2 base pairs, respectively. Compound 2 is the most intercalative 
compound in salmon sperm DNA (35%), while for compound 1 only 11% of the molecules are 
intercalated. Studies of incorporation of both compounds in liposomes of DPPC, Egg-PC and DODAB 
revealed that compound 2 is mainly located in the hydrophobic region of the lipid bilayer, while 
compound 1 prefers a hydrated and fluid environment. 
Introduction 
Liposomes are among technological delivery developments for chemotherapeutic drugs in the 
treatment of cancer. This technique can potentially overcome many common pharmacologic problems, 
such as those involving solubility, pharmacokinetics, in vivo stability and toxicity [1-3]. Liposomes are 
closed spherical vesicles consisting of a lipid bilayer that encapsulates an aqueous phase in which 
hydrophilic drugs can be stored, while water insoluble compounds can be incorporated in the 
hydrophobic region of the lipid bilayer [4]. 
In this work, two new potential antitumoral fluorescent planar tetracyclic thieno[3,2-b]pyridine 
derivatives 1 and 2 (Figure 1), previously synthesized by some of us [5], were encapsulated in 
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liposomes of DPPC (dipalmitoyl phosphatidylcholine), egg lecithin (phosphatidylcholine from egg 
yolk) and DODAB (dioctadecyldimethylammonium bromide). DPPC and egg lecithin [egg yolk 
phosphatidylcholine (Egg-PC)] are neutral components of biological membranes, while cationic 
liposomes based on the synthetic lipid DODAB have been used as vehicles for DNA transfection and 
drug delivery [6]. These studies are important keeping in mind future drug delivery applications using 
these compounds as anticancer drugs. 
Due to the antitumoral potential of the two compounds 1 and 2, related with their possible intercalation 
between the DNA base pairs, interactions with natural double-stranded salmon sperm DNA were 
studied. These interactions can be assessed using spectroscopic measurements, which are important 
tools for monitoring DNA-binding processes. The investigation based on DNA interactions has a key 
importance in order to understand the mechanisms of action of antitumor and antiviral drugs and to 
design new DNA-targeted drugs [7, 8]. Small molecules are stabilized on groove binding and 
intercalation with DNA through a series of associative interactions such as pi-stacking, hydrogen 
bonding, attractive van der Waals and hydrophobic interactions [8]. The occurrence of intercalation 
seems to be an essential (but not sufficient) step for antitumoral activity [7]. Fluorescence quenching 
experiments using external quenchers are also very useful to distinguish between DNA binding modes 
[9] since intercalated molecules are less accessible to anionic quenchers due to electrostatic repulsion 
with negatively charged DNA [10]. 
Experimental 
Salmon sperm DNA from Invitrogen (Carlsbad, CA, USA) and compounds stock solutions were 
prepared in 10 mM Tris–HCl buffer (pH = 7.4), with 1 mM EDTA. The DNA concentration in number 
of bases was determined from the molar absorption coefficient, ε = 6600 M−1 cm−1 at 260 nm [11]. 
Fluorescence spectra of several solutions with different [DNA]/[compound] ratios and constant 
compound concentration (5 × 10−6 M) were recorded. The solutions were left several hours to stabilize. 
Dipalmitoyl phosphatidylcholine (DPPC), egg yolk phosphatidylcholine (Egg-PC), from Sigma-
Aldrich (St. Louis, Missouri, USA), and dioctadecyldimethylammonium bromide (DODAB), from 
Tokyo Kasei (Tokyo, Japan), were used as received. Liposomes were prepared by the ethanolic 
injection method, previously used for the preparation of Egg-PC and DPPC liposomes [12-15] and 
DODAB vesicles [16, 17]. An ethanolic solution of a lipid/compound mixture was injected in an 
aqueous buffer solution under vigorous stirring, above the melting transition temperature of the lipid 
(approx. 41°C for DPPC [18] and 45°C for DODAB [19]). The final lipid concentration was 1 mM, 
with a compound/lipid molar ratio of 1:500. One millilitre solutions of liposome dispersions were 
placed in 3 mL disposable polystyrene cuvettes for dynamic light scattering (DLS) measurements in a 
Malvern ZetaSizer Nano ZS particle analyzer (Worcestershire, UK). Five independent measurements 
were performed for each sample. Malvern Dispersion Technology Software (DTS) (Worcestershire, 
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UK) was used with multiple narrow mode (high resolution) data processing, and mean size (nm) and 
error values were considered. 
Absorption spectra were recorded in a Shimadzu UV-3101PC UV-Vis-NIR spectrophotometer (Kyoto, 
Japan) and fluorescence measurements were obtained in a Fluorolog 3 spectrofluorimeter (HORIBA 
Scientific, Kyoto, Japan) equipped with Glan-Thompson polarizers. Fluorescence spectra were 
corrected for the instrumental response of the system. The fluorescence quantum yields were 
determined by the standard method [20, 21], using 9,10-diphenylanthracene in ethanol as reference, 
Φr = 0.95 [22]. The solutions were previously bubbled for 20 min with ultrapure nitrogen. 
 
Results and discussion 
The size and size distribution of the liposomes prepared was obtained by DLS. All the liposomes have 
a mean hydrodynamic radius lower than 150 nm and generally low polydispersity. For Egg-PC and 
DODAB liposomes, the size distributions are bimodals and broader than for DPPC liposomes, the 
Egg-PC being the more polydisperse (Figure 2). The ethanolic injection method was described to 
produce phospholipid small unilamellar vesicles (SV) [12-15]. Accordingly, DPPC and Egg-PC 
liposomes obtained here are in this category, with a mean diameter of around 90 nm for DPPC and 
50 nm for Egg-PC. DODAB liposomes exhibit a significantly larger mean diameter (around 270 nm) 
than the phospholipid ones. The size of DODAB vesicles strongly depends on the preparation method, 
sonication and ethanolic injection giving small DODAB vesicles [17, 23, 24], while injection using 
chloroform yielded large DODAB vesicles [16]. Besides, spontaneously prepared DODAB liposomes 
have a much larger size (hydrodynamic radius around 337 nm [25]), being considered giant 
unilamellar vesicles (GUV). The DODAB liposomes mean diameter obtained here (ca. 270 nm) 
compares well with the reported value of 249 nm for DODAB SV [16]. In all samples, no 
experimental evidence of the presence of open bilayer fragments (diameter lower than 10 nm [17]) was 
obtained (Figure 2). 
The absorption and fluorescence properties of compounds 1 and 2 were studied in several solvents 
(Table 1). The normalized fluorescence spectra of compounds 1 and 2 are shown in Figures 3 and 4. 
The fluorescence emission maximum of both compounds displays a loss of vibrational structure in 
polar solvents together with a small red shift (Figures 3 and 4), indicating some charge transfer 
character of the excited state [26]. The red shifts are more significant for compound 2 (Table 1), which 
may be due to a higher capability of this compound to establish hydrogen bonds with protic solvents 
(especially with water), due to the presence of the OCH3 group. Compound 1 has significantly higher 
fluorescence quantum yields (between 20 and 30%) than compound 2 (ΦF between 1 and 5%), 
showing that the functionalization of the pyridine ring with a triple bond linked to a p-methoxyphenyl 
group causes a significant enhance of the non-radiative deactivation pathways. The fluorescence 
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quantum yields of compound 1 are also higher than the ones of a benzo[b]thiophene derivative of the 
same type, a benzothienopyridopyrimidone [27], in which the benzene ring linked to the thiophene is 
substituted in compound 1 by a pyridine ring. The intrinsic fluorescence of compounds 1 and 2 can be 
used to monitor interactions with DNA and compounds behaviour when encapsulated in liposomes. 
Both compounds 1 and 2 were tested for their interaction with natural salmon sperm DNA using 
spectroscopic methods. For compound 1, fluorescence intensity decreases with increasing DNA 
concentration, while the opposite happens for compound 2 (Figures 5 and 6). This behaviour, also 
previously observed for differently substituted tetracyclic lactams [28], may indicate a different type of 
interaction of both compounds with the DNA molecule. For the two compounds, full saturation 
(corresponding to spectral invariance with increasing DNA concentration) is attained at 
[DNA]/[compound] = 200, meaning that total binding is achieved at this ratio. The high 
[DNA]/[compound] ratio needed for total binding, together with the negligible changes observed in 
absorption spectra (not shown), point to a weak interaction of these molecules with the nucleic acid. 
The intrinsic binding constants (Ki) and binding site sizes (n) were determined (Table 2) through the 
McGhee and von Hippel modification of Scatchard plot (Equation 1) [29], 
 ( ) ( ) ( )( ) 1i
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where Ki is the intrinsic binding constant, n the binding site size, r the ratio cb/[DNA] and cb and cf the 
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being IF,0 the fluorescence intensity of the free compound and IF,b the fluorescence intensity of the 
bound compound at total binding. The binding constants (Table 2) are moderately low, with a large 
number of base pairs between consecutive intercalated compound molecules (n). 
Anionic quenchers can be useful in distinguishing between DNA binding modes [9, 10]. Compounds 
that are bound at the DNA surface (groove binding or electrostatic binding) are more accessible and 
emission from these molecules can be quenched more efficiently. Fluorescence quenching 
measurements using iodide ion showed that the usual Stern–Volmer plots (plots of the fluorescence 
intensity ratio in the absence, I0, and presence, I, of quencher vs. quencher concentration) are not linear 
and exhibit a downward curvature (Figure 7A). This indicates that some compound molecules are not 
accessible to the anionic quencher, being intercalated between DNA base pairs. The modified Stern–
Volmer plot [30] (Equation 3) allows the determination of the fraction of compound molecules 
accessible to quencher, 
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where I0 is the fluorescence intensity in the absence of quencher, 0I I I∆ = − , KSV the Stern–Volmer 
constant, [Q] the quencher concentration and fa the fraction of molecules accessible to quencher. 
The representations of the modified Stern–Volmer plot are reasonably linear (Figure 7B) and the fa 
values are in Table 2. Both compounds exhibit some intercalation in DNA, compound 2 being the 
more intercalative one, with a lower fraction (65%) of molecules accessible to anionic quencher. The 
higher hydrophobic character of compound 2, promoted by the functionalization of the pyridine with a 
triple bond linked to a p-methoxyphenyl group, may justify this behaviour. As both compounds 1 and 
2 are neutral molecules (and electrostatic interaction with the negatively charged DNA molecule is not 
expected), the high fa values indicate that the main type of interaction with the nucleic acid must be the 
binding to DNA grooves [28]. 
Fluorescence experiments of both compounds encapsulated in liposomes of DPPC, DODAB and Egg-
PC were carried out (Figure 8), in both gel (below Tm) and liquid-crystalline (above Tm) phases. The 
melting transition temperature of Egg-PC is very low [31] and this lipid is in the fluid liquid-crystalline 
phase at room temperature. Fluorescence spectra of compound 1 incorporated in liposomes (Figure 8, 
Table 3) are roughly similar to the one obtained in pure water, regarding the band shape and maximum 
emission wavelength. Compound 2 in liposomes presents emission spectra similar to those in polar 
solvents, significantly blue-shifted relative to water. In Egg-PC, a band enlargement is observed in the 
blue region, which can indicate two different locations of compound 2 in these liposomes, one deep in 
the hydrophobic region and another more close to the lipid polar heads. 
Fluorescence anisotropy (r) measurements (Table 3) can give relevant information about the location 
of the compounds in liposomes, as r increases with the rotational correlation time of the fluorescent 
molecule (and, thus, with the viscosity of the fluorophore environment) [26]. Anisotropy values in a 
viscous solvent (glycerol) were also determined, for comparison. Anisotropy results (Table 3) allow to 
conclude that compound 2 is mainly located in the inner region of the lipid bilayer, feeling the 
penetration of some water molecules. The transition from the rigid gel phase to the liquid-crystalline 
phase is clearly detected by a significant decrease in anisotropy at 55°C observed in DPPC and 
DODAB liposomes. Compound 1 exhibits a different behaviour and anisotropy is very low in all types 
of liposomes (and much lower than in glycerol, Table 3). Overall, the results indicate that compound 1 
prefers a hydrated and fluid environment and the transition from the gel phase to the liquid-crystalline 
phase is not detected. To further clarify the location of compound 1, the solutions of liposomes with 
incorporated compound were passed through filters of 0.05 µm diameter. The fluorescence emission of 
the filtered solutions was negligible, indicating that compound 1 is mainly in the liposome aqueous 
interior or located at the interfaces, with a very hydrated environment. This behaviour is similar to the 
observed previously for a benzothienopyridopyrimidone in lipid vesicles [27]. The encapsulation 
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assays performed here may be important for future drug delivery applications of these potential 
antitumoral compounds using liposomes as drug carriers. 
 
Conclusions 
The interaction with DNA of two new potential antitumoral fluorescent planar thieno[3,2-b]pyridine 
derivatives was studied using spectroscopic methods. Compound 2 was shown to be the most 
intercalative compound in salmon sperm DNA (35%). The binding to DNA grooves seems to be the 
main type of interaction with the nucleic acid. Studies of incorporation of both compounds in 
liposomes of DPPC, Egg-PC and DODAB revealed that compound 2 is mainly located in the 
hydrophobic region of the lipid bilayer, while compound 1 prefers a hydrated and fluid environment. 
Our data thus suggest that both potential antitumoral compounds may be transported in liposomes for 
drug delivery applications. 
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Figure 1. Structure of the compounds 1 and 2. 
Figure 2. Size distributions obtained by dynamic light scattering (DLS) for DPPC, Egg-PC and 
DODAB liposomes prepared by the ethanolic injection method. 
Figure 3. Normalized fluorescence spectra (λexc = 360 nm) of compound 1 (4 × 10−6 M) in several 
solvents; the inset shows  the absorption spectrum of 1 in dichloromethane (1 × 10−4 M) as an 
example. 
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Figure 4. Normalized fluorescence spectra (λexc = 360 nm) of compound 2 (4 × 10−6 M) in several 
solvents; the inset shows the absorption spectrum of 2 in dichloromethane (2 × 10−5 M) as an 
example. 
Figure 5. Fluorescence spectra of compound 1 (5 × 10−6 M) in 0.01 M Tris–HCl buffer (pH = 7.2), 
with increasing DNA content. 
Figure 6. Fluorescence spectra of compound 2 (5 × 10−6 M) in 0.01 M Tris–HCl buffer (pH = 7.2), 
with increasing DNA content. 
Figure 7.  Stern–Volmer plots for quenching with iodide ion of compounds 1 and 2 for 
[DNA]/[compound] = 200 (A) and corresponding modified Stern–Volmer plots (B).  
Figure 8. Normalized fluorescence emission spectra of compounds 1 and 2 incorporated in 
liposomes of DPPC, Egg-PC and DODAB. 
 
Table 1. Maximum absorption (λabs) and emission (λem) wavelengths, molar absorption 
coefficients (ε) and fluorescence quantum yields of compounds 1 and 2 in several solvents. 
λabs (nm) (ε/104 M−1 cm−1) λem (nm) ΦF Solvent 
1 2 1 2 1 2 
Cyclohexane 398 (0.84); 377 (1.24); 360 (1.27); 305 (0.95); 258 (3.93) 
411 sh (0.33); 354 (2.19); 347 
(2.37); 308 (1.25); 291 (1.12); 
270 (1.40) 
402; 426; 
452 sh 
417; 
441 0.20 0.047 
Dioxane 398 (0.76); 377 (1.18); 359 (1.20); 305 (1.17); 258 (3.60) 
411 sh (0.66); 356 (5.36); 346 
(5.40); 309 (3.23); 291 (2.98); 
272 (3.33) 
407; 428; 
455 sh 
425; 
449 0.29 0.054 
Dichloromethane 397 (0.58); 377 (0.91); 360 (0.93); 305 (0.97); 259 (2.70) 
410 sh (0.55); 357 (4.37); 311 
(2.28); 290 (2.29); 273 (2.78) 408; 429 
427; 
448 0.26 0.022 
Acetonitrile 395 (0.68); 376 (1.06); 358 (1.06); 304 (1.09); 256 (3.32) 
409 sh (0.66); 355 (5.76); 308 
(3.41); 289 (3.20); 271 (3.67) 408; 428 450 0.21 0.036 
N,N-
Dimethylformamidea 
397 (0.78); 377 (1.19); 360 (1.16); 305 
(1.19) 
411 sh (0.69); 356 (5.52); 311 
(3.11); 290 (2.86) 411; 430 453 0.30 0.047 
Dimethylsulfoxidea 397 (0.77); 378 (1.17); 361 (1.14); 305 (1.17) 
412 sh (0.61); 357 (4.70); 313 
(2.52) 413; 432 455 0.28 0.048 
Ethanol 396 (0.69); 375 (1.13); 358 (1.17); 304 (1.40); 256 (3.59) 
408 sh (0.72); 355 (5.50); 311 
(2.95); 272 (3.69) 412; 431 452 0.27 0.041 
Methanol 395 (0.67); 374 (1.08); 358 (1.10); 304 (1.34); 256 (3.43) 
408 sh (0.62); 354 (5.00); 311 
(2.80); 272 (3.41) 413; 433 453 0.26 0.040 
Water 394 (0.41); 374 (0.57); 361 (0.58); 303 (0.93); 256 (2.07) 
420 sh (0.26); 358 (0.87); 314 
(0.94); 278 (0.97) 
413 sh; 
433 505 0.22 0.012 
aSolvent cut-offs: N,N-Dimethylformamide: 275 nm; Dimethylsulfoxide: 280 nm; sh: shoulder. 
 
 
Table 2. Values of the intrinsic binding constants (Ki) and binding site sizes (n) and fraction of 
compound molecules accessible to external quenchers (fa) for interaction with salmon sperm 
DNA. 
Compound Ki (M−1) n fa 
1 (8.7 ± 0.9) × 103 11 ± 3 0.89 
2 (5.9 ± 0.6) × 103 7 ± 2 0.65 
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Table 3. Steady-state fluorescence anisotropy (r) values and maximum emission wavelengths 
(λem) of compounds 1 and 2 incorporated in liposomes.  
Compound 1 Compound 2  
λem/nm r λem/nm r 
DPPC (25°C) 433 0.009 453 0.111 
DPPC (55°C) 434 0.008 454 0.032 
Egg-PC (25°C) 432 0.008 453 0.095 
DODAB (25°C) 433 0.011 454 0.112 
DODAB (55°C) 432 0.007 455 0.051 
Glycerol (25°C) 437 0.166 472 0.202 
Values in glycerol are also shown for comparison. 
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